如何在保健产品的整个生命周期中考虑其环境可持续性?

IF 2.2 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Bruno Laviolle , Pierre-Frédéric Degon , Cécile Gillet-Giraud , Dominique Thiveaud , Philippe Lechat , Vera Boïko-Alaux , Claire Fougerou , Clara Jolly , Abir Petit , Isabelle Rémy-Jouet , Raphaël Yven , Laurence Bouret , Laurie Marrauld , Marie-Pierre Vaslet , Virginie Delay , Anne-Laure Gavory , Florence Olle , Julie Langevin , Louise Forteau
{"title":"如何在保健产品的整个生命周期中考虑其环境可持续性?","authors":"Bruno Laviolle ,&nbsp;Pierre-Frédéric Degon ,&nbsp;Cécile Gillet-Giraud ,&nbsp;Dominique Thiveaud ,&nbsp;Philippe Lechat ,&nbsp;Vera Boïko-Alaux ,&nbsp;Claire Fougerou ,&nbsp;Clara Jolly ,&nbsp;Abir Petit ,&nbsp;Isabelle Rémy-Jouet ,&nbsp;Raphaël Yven ,&nbsp;Laurence Bouret ,&nbsp;Laurie Marrauld ,&nbsp;Marie-Pierre Vaslet ,&nbsp;Virginie Delay ,&nbsp;Anne-Laure Gavory ,&nbsp;Florence Olle ,&nbsp;Julie Langevin ,&nbsp;Louise Forteau","doi":"10.1016/j.therap.2023.12.001","DOIUrl":null,"url":null,"abstract":"<div><p>Healthcare product procurement accounts for around 50% of the French healthcare system's greenhouse gas emissions. This lesson learned from the publication of the Shift Project's work in November 2021 has been a catalyst within the healthcare system, accelerating the consideration and implementation of actions aimed at reducing the environmental impact of the healthcare system, before, during and after care. In addition to their carbon footprint, healthcare products have a wide range of environmental impacts, including on water, air and soil, throughout their entire life cycle. We have chosen to divide this life cycle into four main stages: from research and development to production, distribution and market access, use and finally end-of-life management. Analysis of the regulatory framework at each stage and of existing initiatives described in the literature or by those in the field have structured and fuelled our thinking. We found that existing regulations focus exclusively on the health risk, with little or no consideration of the environmental risk, which is in itself a health risk. Furthermore, the implementation of certain structuring actions during the first 3 stages of the life cycle would make it possible to simplify or even eliminate the major problem of waste management associated with the end-of-life of healthcare products. With this in mind, we have produced 9 recommendations to ensure that the environmental impact of healthcare products is better taken into account throughout their life cycle.</p></div>","PeriodicalId":23147,"journal":{"name":"Therapie","volume":"79 1","pages":"Pages 61-74"},"PeriodicalIF":2.2000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How can the environmental sustainability of healthcare products be taken into account throughout their life cycle?\",\"authors\":\"Bruno Laviolle ,&nbsp;Pierre-Frédéric Degon ,&nbsp;Cécile Gillet-Giraud ,&nbsp;Dominique Thiveaud ,&nbsp;Philippe Lechat ,&nbsp;Vera Boïko-Alaux ,&nbsp;Claire Fougerou ,&nbsp;Clara Jolly ,&nbsp;Abir Petit ,&nbsp;Isabelle Rémy-Jouet ,&nbsp;Raphaël Yven ,&nbsp;Laurence Bouret ,&nbsp;Laurie Marrauld ,&nbsp;Marie-Pierre Vaslet ,&nbsp;Virginie Delay ,&nbsp;Anne-Laure Gavory ,&nbsp;Florence Olle ,&nbsp;Julie Langevin ,&nbsp;Louise Forteau\",\"doi\":\"10.1016/j.therap.2023.12.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Healthcare product procurement accounts for around 50% of the French healthcare system's greenhouse gas emissions. This lesson learned from the publication of the Shift Project's work in November 2021 has been a catalyst within the healthcare system, accelerating the consideration and implementation of actions aimed at reducing the environmental impact of the healthcare system, before, during and after care. In addition to their carbon footprint, healthcare products have a wide range of environmental impacts, including on water, air and soil, throughout their entire life cycle. We have chosen to divide this life cycle into four main stages: from research and development to production, distribution and market access, use and finally end-of-life management. Analysis of the regulatory framework at each stage and of existing initiatives described in the literature or by those in the field have structured and fuelled our thinking. We found that existing regulations focus exclusively on the health risk, with little or no consideration of the environmental risk, which is in itself a health risk. Furthermore, the implementation of certain structuring actions during the first 3 stages of the life cycle would make it possible to simplify or even eliminate the major problem of waste management associated with the end-of-life of healthcare products. With this in mind, we have produced 9 recommendations to ensure that the environmental impact of healthcare products is better taken into account throughout their life cycle.</p></div>\",\"PeriodicalId\":23147,\"journal\":{\"name\":\"Therapie\",\"volume\":\"79 1\",\"pages\":\"Pages 61-74\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0040595723001932\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0040595723001932","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

医疗保健产品的采购约占法国医疗保健系统温室气体排放量的 50%。2021 年 11 月发布的 "转变项目 "工作总结出的这一经验在医疗保健系统内起到了催化剂的作用,加速了对旨在减少医疗保健系统在护理前、护理中和护理后对环境影响的行动的考虑和实施。除了碳足迹之外,医疗保健产品在其整个生命周期中还会对环境产生广泛的影响,包括对水、空气和土壤的影响。我们选择将这一生命周期分为四个主要阶段:从研发到生产、分销和市场准入、使用以及最后的生命周期终期管理。对每个阶段的监管框架以及文献中描述的或该领域人士提出的现有倡议的分析,为我们的思考提供了依据和动力。我们发现,现有法规只关注健康风险,很少或根本没有考虑环境风险,而环境风险本身也是一种健康风险。此外,在生命周期的前 3 个阶段实施某些结构化行动,将有可能简化甚至消除与保健产品生命周期终结相关的废物管理这一重大问题。有鉴于此,我们提出了 9 项建议,以确保在保健产品的整个生命周期中更好地考虑其对环境的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
How can the environmental sustainability of healthcare products be taken into account throughout their life cycle?

Healthcare product procurement accounts for around 50% of the French healthcare system's greenhouse gas emissions. This lesson learned from the publication of the Shift Project's work in November 2021 has been a catalyst within the healthcare system, accelerating the consideration and implementation of actions aimed at reducing the environmental impact of the healthcare system, before, during and after care. In addition to their carbon footprint, healthcare products have a wide range of environmental impacts, including on water, air and soil, throughout their entire life cycle. We have chosen to divide this life cycle into four main stages: from research and development to production, distribution and market access, use and finally end-of-life management. Analysis of the regulatory framework at each stage and of existing initiatives described in the literature or by those in the field have structured and fuelled our thinking. We found that existing regulations focus exclusively on the health risk, with little or no consideration of the environmental risk, which is in itself a health risk. Furthermore, the implementation of certain structuring actions during the first 3 stages of the life cycle would make it possible to simplify or even eliminate the major problem of waste management associated with the end-of-life of healthcare products. With this in mind, we have produced 9 recommendations to ensure that the environmental impact of healthcare products is better taken into account throughout their life cycle.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Therapie
Therapie 医学-药学
CiteScore
3.50
自引率
7.70%
发文量
132
审稿时长
57 days
期刊介绍: Thérapie is a peer-reviewed journal devoted to Clinical Pharmacology, Therapeutics, Pharmacokinetics, Pharmacovigilance, Addictovigilance, Social Pharmacology, Pharmacoepidemiology, Pharmacoeconomics and Evidence-Based-Medicine. Thérapie publishes in French or in English original articles, general reviews, letters to the editor reporting original findings, correspondence relating to articles or letters published in the Journal, short articles, editorials on up-to-date topics, Pharmacovigilance or Addictovigilance reports that follow the French "guidelines" concerning good practice in pharmacovigilance publications. The journal also publishes thematic issues on topical subject. The journal is indexed in the main international data bases and notably in: Biosis Previews/Biological Abstracts, Embase/Excerpta Medica, Medline/Index Medicus, Science Citation Index.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信